NEUROGASTROENTEROLOGY

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

E F Verdú¹, P Bercik¹, M Verma-Gandhu¹, X-X Huang¹, P Blennerhassett¹, W Jackson¹, Y Mao¹, L Wang¹, F Rochat², S M Collins¹

¹ IDRP, McMaster University, Hamilton, Canada
² Department of Nutrition and Health, Nestlé Research Centre, Lausanne, Switzerland

Correspondence to:
Dr E F Verdu
Intestinal Disease Research Program, 1200 Main S West, Hamilton, Ontario, Canada; verdue{at}mcmaster.ca

Background and aim: Abdominal pain and discomfort are common symptoms in functional disorders and are attributed to visceral hypersensitivity. These symptoms fluctuate over time but the basis for this is unknown. Here we examine the impact of changes in gut flora and gut inflammatory cell activity on visceral sensitivity.

Methods: Visceral sensitivity to colorectal distension (CRD) was assessed at intervals in healthy mice for up to 12 weeks, and in mice before and after administration of dexamethasone or non-absorbable antibiotics with or without supplementation with Lactobacillus paracasei (NCC2461). Tissue was obtained for measurement of myeloperoxidase activity (MPO), histology, microbiota analysis, and substance P (SP) immunolabelling.

Results: Visceral hypersensitivity developed over time in healthy mice maintained without sterile precautions. This was accompanied by a small increase in MPO activity. Dexamethasone treatment normalised MPO and CRD responses. Antibiotic treatment perturbed gut flora, increased MPO and SP immunoreactivity in the colon, and produced visceral hypersensitivity. Administration of Lactobacillus paracasei in spent culture medium normalised visceral sensitivity and SP immunolabelling, but not intestinal microbiota counts.

Conclusion: Perturbations in gut flora and in inflammatory cell activity alter sensory neurotransmitter content in the colon, and result in altered visceral perception. Changes in gut flora may be a basis for the variability of abdominal symptoms observed in functional gastrointestinal disorders and may be prevented by specific probiotic administration.

Abbreviations: IBS, irritable bowel syndrome; SPF, specific pathogen free; CRD, colorectal distension; MPO, myeloperoxidase; SCM, spent culture medium; SP, substance P; MRS, Man-Rogosa-Sharpe broth; EMG, electromyographic; CFU, colony forming units

Keywords: probiotic therapy; visceral hypersensitivity; gut flora; inflammation; mice

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller and Alistair Watson
Gut 2006 55: 141. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Verdu, E. F., Bercik, P., Collins, S. M. (2009). Review: Effect of probiotics on gastrointestinal function: evidence from animal models. Therapeutic Advances in Gastroenterology 2: s31-s35 [Abstract]  
• Matsunami, M, Tarui, T, Mitani, K, Nagasawa, K, Fukushima, O, Okubo, K, Yoshida, S, Takemura, M, Kawabata, A (2009). Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 58: 751-761 [Abstract] [Full Text]  
• Ma, X., Mao, Y.-K., Wang, B., Huizinga, J. D., Bienenstock, J., Kunze, W. (2009). Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G868-G875 [Abstract] [Full Text]  
• Vanner, S (2008). The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Gut 57: 1315-1321 [Full Text]  
• Barreau, F, Salvador-Cartier, C, Houdeau, E, Bueno, L, Fioramonti, J (2008). Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut 57: 582-590 [Abstract] [Full Text]  
• Collins, S. M. (2007). Translating symptoms into mechanisms: functional GI disorders. Adv. Physiol. Educ. 31: 329-331 [Abstract] [Full Text]  
• Quigley, E. M M (2007). Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy?. J. Am. Coll. Nutr. 26: 684S-690S [Abstract] [Full Text]  
• Eutamene, H., Lamine, F., Chabo, C., Theodorou, V., Rochat, F., Bergonzelli, G. E., Corthesy-Theulaz, I., Fioramonti, J., Bueno, L. (2007). Synergy between Lactobacillus paracasei and Its Bacterial Products to Counteract Stress-Induced Gut Permeability and Sensitivity Increase in Rats. J. Nutr. 137: 1901-1907 [Abstract] [Full Text]  
• Verma-Gandhu, M., Verdu, E. F, Bercik, P., Blennerhassett, P. A, Al-Mutawaly, N., Ghia, J.-E., Collins, S. M (2007). Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut 56: 358-364 [Abstract] [Full Text]  
• Ait-Belgnaoui, A, Han, W, Lamine, F, Eutamene, H, Fioramonti, J, Bueno, L, Theodorou, V (2006). Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 55: 1090-1094 [Abstract] [Full Text]